Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.

Longo JF, Brosius SN, Black L, Worley SH, Wilson RC, Roth KA, Carroll SL.

Cell Commun Signal. 2019 Jul 10;17(1):74. doi: 10.1186/s12964-019-0388-5.

2.

Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.

Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, Bedwell DM, Zinn KR, Anastasaki C, Gutmann DH, Korf BR, Kesterson RA.

Dis Model Mech. 2016 Jul 1;9(7):759-67. doi: 10.1242/dmm.025783. Epub 2016 Jun 2.

3.

Reversible improvement in severe freezing of gait from Parkinson's disease with unilateral interleaved subthalamic brain stimulation.

Brosius SN, Gonzalez CL, Shuresh J, Walker HC.

Parkinsonism Relat Disord. 2015 Dec;21(12):1469-70. doi: 10.1016/j.parkreldis.2015.09.047. Epub 2015 Oct 8.

PMID:
26482492
4.

Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.

Brossier NM, Prechtl AM, Longo JF, Barnes S, Wilson LS, Byer SJ, Brosius SN, Carroll SL.

J Neuropathol Exp Neurol. 2015 Jun;74(6):568-86. doi: 10.1097/NEN.0000000000000201.

5.

Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.

Brosius SN, Turk AN, Byer SJ, Longo JF, Kappes JC, Roth KA, Carroll SL.

J Neuropathol Exp Neurol. 2014 Nov;73(11):1078-90. doi: 10.1097/NEN.0000000000000126.

6.

Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.

Brosius SN, Turk AN, Byer SJ, Brossier NM, Kohli L, Whitmire A, Mikhail FM, Roth KA, Carroll SL.

Acta Neuropathol. 2014 Apr;127(4):573-91.

Supplemental Content

Loading ...
Support Center